Moreover, DPP-4i could have anti-cancer effects by modulating the DPP-4/SDF-1/CXCR4 axis and the immune balance, enhancing tumor rejection by preserving biologically active CXCL10 and increasing trafficking into the tumor by lymphocytes [71]. This evidence concerns the gene CXCL10 and neoplasm.